| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0002 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |